RP-HPLC is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-02. Numbers and descriptions here follow the published literature rather than marketing material.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.
The molecule contains five residues, including alpha-aminoisobutyric acid, D-2-naphthylalanine, and D-phenylalanine, and it ends in a lysine amide. Non-natural and D-configured residues make the chain less susceptible to common peptidases, which helps explain its resistance to rapid breakdown. Its molecular formula is C38H49N9O5, corresponding to a free-base mass near 711.9 daltons. The C-terminal amide removes a negative charge and is a recurring feature in receptor-active peptides of this family. These structural choices are usually discussed as the basis for its selectivity profile.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with C-terminal amide |
| Average mass | Approximately 711.9 Da | Value derived from the formula |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and aqueous acetonitrile | Dissolution aided by acidic diluents |
| Common synonyms | Ipamorelin; NNC 26-0161 | Code name used in early reports |
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
Peptides such as ipamorelin are subject to chemical and physical degradation. Hydrolysis of peptide bonds, oxidation of susceptible residues, and aggregation are common pathways that reduce purity over time. The rate of these processes depends on temperature, moisture, pH, and the number of freeze-thaw cycles a sample undergoes. Because the compound is typically handled as a lyophilized powder, controlling moisture during storage is a central concern. Degradation products can be detected with separation techniques that resolve the parent peptide from related impurities.
Lyophilized material is generally stored frozen and protected from light and moisture. Typical recommendations place dry powder at temperatures well below freezing, while reconstituted solutions are kept cold and used within a defined window. Repeated freezing and thawing should be avoided because it can promote aggregation and loss of material. The choice of solvent matters as well; compatibility with the intended diluent should be checked before preparation. These handling practices aim to preserve both the quantity and the integrity of the peptide.
Verification of identity and purity relies on analytical methods used across peptide chemistry. Reverse-phase high-performance liquid chromatography separates components by hydrophobicity and provides a purity estimate. Mass spectrometry confirms molecular mass and helps detect modifications. Together these techniques give complementary information about whether a sample matches its expected structure. Results depend on method parameters and reference standards, so reported purity values are meaningful only when the analytical conditions are stated. Consistency between laboratories requires comparable protocols and well-characterized reference materials.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
Identity and purity are assessed by complementary methods rather than a single test. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and reports a percentage purity. Mass spectrometry, most often with electrospray ionization, confirms the expected molecular mass and detects sequence-related variants. Amino acid analysis can verify composition, while water content and residual counterion measurements support the mass balance of a batch. Stability studies under accelerated conditions are used to estimate shelf life, though such estimates carry uncertainty for long-term storage.
In engineering, the elasticity of a material is quantified by the elastic modulus such as the Young's modulus, bulk modulus or shear modulus which measure the amount of stress needed to achieve a unit of strain; a higher modulus indicates that the material is harder to deform. The SI unit of this modulus is the pascal (Pa). The material's elastic limit or yield strength is the maximum stress that can arise before the onset of plastic deformation. Its SI unit is also the pascal (Pa).
=== Deactivation === The bioactivity of calcitriol is terminated by hydroxylation at position 24 by vitamin D3 24-hydroxylase, coded for by gene CYP24A1, forming calcitetrol. Further metabolism yields calcitroic acid, an inactive water-soluble compound that is excreted in bile. Vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) share a similar but not identical mechanism of action. Metabolites produced by vitamin D2 are named with an er- or ergo- prefix to differentiate them from the D3-based counterparts (sometimes with a chole- prefix).
In January 2025, President Donald Trump signed an executive order demanding that various drug cartels and criminal organizations (Sinaloa Cartel, Gulf Cartel, La Nueva Familia Michoacana, Jalisco New Generation Cartel, Northeast Cartel, United Cartels, Tren de Aragua and Mara Salvatrucha) be added to the list of Foreign Terrorist Organizations and Specially Designated Global Terrorists, which was officially enacted on 20 February, 2025, making such groups officially Foreign Terrorist Organizations. Similarly, Canada has also joined in designating drug cartels as Foreign Terrorist Organizations. Also, in the same year, the United States similarly designated and added the Los Lobos and Los Choneros gangs to the list of foreign terrorist organizations. On October 1, 2025, in the context of Operation Southern Spear and the US naval deployment in the Caribbean, President Donald Trump formally declared that the US is engaged in a "non-international armed conflict" with "unlawful combatants" associated with drug cartels operating in the Caribbean. This legal shift enabled operations such as the recent Operation Absolute Resolve on January 3, 2026, in which US special forces captured former Venezuelan leader Nicolás Maduro in Caracas on charges of narco-terrorism.
Sources: en.wikipedia.org
Corn and sugar cane are C4 plants, whereas the plants used by bees to produce honey, as well as sugar beet, are predominantly C3 plants. Sugars derived from C4 plants alter the isotopic ratio of sugars in honey but do not affect the isotopic ratio of proteins. In unadulterated honey, the carbon isotopic ratios of sugars and proteins are expected to match. Using this method, adulteration levels as low as seven per cent can be detected.
=== Research === Although bilberries have been used in traditional medicine, there are no proven health benefits or antidisease effects from consuming them. One review of low-quality clinical research concluded there was no evidence that consuming bilberries improves night vision.
In April 2007, Dein left Arsenal due to "irreconcilable differences" about the future of the club. Wenger described it as a "sad day for Arsenal," and sought assurances from the board over his future as well as reasons for Dein's departure. The instability at board level influenced club captain Henry's decision to leave Arsenal in June 2007, which led to uncertainty over Wenger's position. In September 2007, Wenger signed a new three-year extension, stating that he remained committed to "the club of my life." (In 2021, Wenger revealed that his signing of the contract extension was his side of a deal with the Arsenal board in the building of the new stadium, because he requested its construction.) Arsenal flourished in Henry's absence, with Emmanuel Adebayor, Mathieu Flamini and Fàbregas playing a more prominent role in the 2007–08 season. Defeat to Middlesbrough in December 2007 ended a run of 22 league matches unbeaten, but Arsenal soon built a five-point lead over Manchester United. A career-threatening injury to striker Eduardo against Birmingham City on 23 February 2008 acted as a turning point in Arsenal's season. Wenger, incensed at the aggressive tactics of opponents, called for a ban on tackler Martin Taylor in his post-match interview; he later retracted the comment. Arsenal's form subsequently suffered, and a run of three consecutive draws in March allowed Manchester United and Chelsea to overhaul them as they finished the season in third. Arsenal made a troubled start to Wenger's twelfth season.
Present-day Ningxia is one of the nation's smallest provincial-level units and borders the provinces of Shaanxi and Gansu and the Inner Mongolia Autonomous Region. At 3556 meters above sea level, Aobaogeda (敖包疙瘩) in the Helan Mountains is the highest point in Ningxia. Ningxia is a relatively dry, desert-like region and features a diverse geography of forested mountains and hills, table lands, deserts, flood plains and basins cut through by the Yellow River. The Ningxia ecosystem is one of the least studied regions in the world. Significant irrigation supports the growing of wolfberries, a commonly consumed fruit throughout the region. Ningxia's deserts include the Tengger Desert in Shapotou. The northern section, through which the Yellow River flows, supports the best agricultural land. A railroad, linking Lanzhou with Baotou, crosses the region. A highway has been built across the Yellow River at Yinchuan. On 16 December 1920, the Haiyuan earthquake, 8.6 magnitude, at 36.6°N 105.32°E / 36.6; 105.32, initiated a series of landslides that killed an estimated 200,000 people. Over 600 large loess landslides created more than 40 new lakes.
Sources: en.wikipedia.org
It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.
It has not received marketing approval as a medicine in the United States or the European Union. Supplied material is generally described and handled as a research chemical. Regulatory treatment varies by jurisdiction, and some countries restrict growth hormone secretagogues under sports or medicines legislation.
Earlier secretagogues were associated with broader hormonal responses, including measurable changes in cortisol and prolactin. Reports on this peptide describe a narrower profile in which growth hormone release is the most prominent effect. The observation is influential because it shapes how the compound is compared with other members of the same receptor family.
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.